Home | About Us | Contact Us
Best Seller
Opportunities in Indian Healthcare Sector By RNCOS
Search by Keyword

All Research Reports

Latest Research by Email
Receive email alerts of new market research reports in your industry.

Contact Us
US:+1 (646) 3678214
India:+91 (11) 42141228
E-mail: sales@marketsmonitor.com

Global Pharmaceutical Market Forecast to 2012, Market Research Reports, Marketing and Business Research, Industry Analysis

Global Pharmaceutical Market Forecast to 2012

Publisher: RNCOS Publish Date:  Dec, 2009 No. of Pages: 170
Delivery: Adobe Reader (PDF) Upto 24 hour delivery
Global Pharmaceutical Market Forecast to 2012
  Electronic Access - Single User License   US$ 1800.00
  CD-ROM Mail Delivery   US$ 2100.00
  Hard Copy Mail Delivery   US$ 2100.00
  Electronic Access - Multi-User License   US$ 2800.00
Abstract
Table of Content
List of Figures & Tables
Related Reports

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2008
Figure 2-5: Global - Leading Pharmaceutical Companies by Sales (Billion US$), 2008
Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-3: US - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2007-2009
Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2010-2012
Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-15: Chile - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-16: Chile - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-19: Germany - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-20: Germany - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-21: France - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-22: France - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-23: Italy - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-24: Italy - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-25: Spain - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-26: Spain - Share of Prescription & OTC Drugs in Pharmaceutical Market (2008)
Figure 3-27: Spain - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-28: UK - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-29: UK - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-30: Russia - Pharmaceutical Market (Billion Rubles), 2007-2009
Figure 3-31: Russia - Share of Commercial & State Sector in Pharmaceutical Market (2008)
Figure 3-32: Russia - Share of Imported & Domestically-produced Drugs in Pharmaceutical Market (2008)
Figure 3-33: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2010-2012
Figure 3-34: Turkey - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-35: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 3-36: Turkey - Share of Therapy Areas in Pharmaceutical Market (2008)
Figure 3-37: Turkey - Share of Imported & Domestically-produced Drugs in Pharmaceutical Market (2008)
Figure 3-38: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-39: Poland - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-40: Poland - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-41: Hungary - Pharmaceutical Market (Million €), 2007-2009
Figure 3-42: Hungary - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-43: Ukraine - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-44: Ukraine - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-45: Czech Republic - Pharmaceutical Market (Million €), 2007-2009
Figure 3-46: Czech Republic - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-47: Romania - Pharmaceutical Market (Million €), 2007-2009
Figure 3-48: Romania - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-49: Asia-Pacific - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-50: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-51: India - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-52: India - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-53: China - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-54: China - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-55: Japan - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-56: Japan - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-57: South Korea - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-58: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-59: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2009
Figure 3-60: Indonesia - Forecast for Pharmaceutical Market (Trillion Rp), 2010-2012
Figure 3-61: Vietnam - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-62: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-63: Thailand - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-64: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-65: Philippines - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-66: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-67: Malaysia - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-68: Malaysia - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-69: Saudi Arabia - Pharmaceutical Market (Billion SR), 2007-2009
Figure 3-70: Saudi Arabia - Sales of Imported & Domestically-produced Pharmaceuticals (Billion SR), 2004-2007
Figure 3-71: Saudi Arabia - Forecast for Pharmaceutical Market (Billion SR), 2010-2012
Figure 3-72: UAE - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-73: UAE - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-74: Australia - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-75: Australia - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-76: New Zealand - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-77: New Zealand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-78: South Africa - Pharmaceutical Market (Billion ZAR), 2007-2009
Figure 3-79: South Africa - Forecast for Pharmaceutical Market (Billion ZAR), 2010-2012
Figure 3-80: Egypt - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-81: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-82: Nigeria - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-83: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2010-2012

List of Tables:

Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2008
Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2008
Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2008
Table 3-1: US - Healthcare Statistics (2007-2009)
Table 3-2: US - Forecast for Healthcare Statistics (2010-2012)
Table 3-3: Canada - Healthcare Statistics (2007-2009)
Table 3-4: Canada - Forecast for Healthcare Statistics (2010-2012)
Table 3-5: Brazil - Healthcare Statistics (2007-2009)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2010-2012)
Table 3-7: Mexico - Healthcare Statistics (2007-2009)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2010-2012)
Table 3-9: Argentina - Healthcare Statistics (2007-2009)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2010-2012)
Table 3-11: Chile - Healthcare Statistics (2007-2009)
Table 3-12: Chile - Forecast for Healthcare Statistics (2010-2012)
Table 3-13: Germany - Healthcare Statistics (2007-2009)
Table 3-14: Germany - Forecast for Healthcare Statistics (2010-2012)
Table 3-15: France - Healthcare Statistics (2007-2009)
Table 3-16: France - Forecast for Healthcare Statistics (2010-2012)
Table 3-17: Italy - Healthcare Statistics (2007-2009)
Table 3-18: Italy - Forecast for Healthcare Statistics (2010-2012)
Table 3-19: Spain - Healthcare Statistics (2007-2009)
Table 3-20: Spain - Forecast for Healthcare Statistics (2010-2012)
Table 3-21: UK - Healthcare Statistics (2007-2009)
Table 3-22: UK - Forecast for Healthcare Statistics (2010-2012)
Table 3-23: Russia - Healthcare Statistics (2007-2009)
Table 3-24: Russia - Forecast for Healthcare Statistics (2010-2012)
Table 3-25: Turkey - Healthcare Statistics (2007-2009)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2010-2012)
Table 3-27: Poland - Healthcare Statistics (2007-2009)
Table 3-28: Poland - Forecast for Healthcare Statistics (2010-2012)
Table 3-29: Hungary - Healthcare Statistics (2007-2009)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2010-2012)
Table 3-31: Ukraine - Healthcare Statistics (2007-2009)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2010-2012)
Table 3-33: Czech Republic - Healthcare Statistics (2007-2009)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2010-2012)
Table 3-35: Romania - Healthcare Statistics (2007-2009)
Table 3-36: Romania - Forecast for Healthcare Statistics (2010-2012)
Table 3-37: India - Healthcare Statistics (2007-2009)
Table 3-38: India - Forecast for Healthcare Statistics (2010-2012)
Table 3-39: China - Healthcare Statistics (2007-2009)
Table 3-40: China - Forecast for Healthcare Statistics (2010-2012)
Table 3-41: Japan - Healthcare Statistics (2007-2009)
Table 3-42: Japan - Forecast for Healthcare Statistics (2010-2012)
Table 3-43: South Korea - Healthcare Statistics (2007-2009)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2010-2012)
Table 3-45: Indonesia - Healthcare Statistics (2007-2009)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2010-2012)
Table 3-47: Vietnam - Healthcare Statistics (2007-2009)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2010-2012)
Table 3-49: Thailand - Healthcare Statistics (2007-2009)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2010-2012)
Table 3-51: Philippines - Healthcare Statistics (2007-2009)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2010-2012)
Table 3-53: Malaysia - Healthcare Statistics (2007-2009)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2010-2012)
Table 3-55: Saudi Arabia - Healthcare Statistics (2007-2009)
Table 3-56: Saudi Arabia - Forecast for Healthcare Statistics (2010-2012)
Table 3-57: Australia - Healthcare Statistics (2007-2009)
Table 3-58: Australia - Forecast for Healthcare Statistics (2010-2012)
Table 3-59: New Zealand - Healthcare Statistics (2007-2009)
Table 3-60: New Zealand - Forecast for Healthcare Statistics (2010-2012)
Table 3-61: South Africa - Healthcare Statistics (2007-2009)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2010-2012)
Table 3-63: Egypt - Healthcare Statistics (2007-2009)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2010-2012)
Table 3-65: Nigeria - Healthcare Statistics (2007-2009)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2010-2012)
Table 4-1: Pfizer Inc - Strengths & Weaknesses
Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-4: Novartis International AG - Strengths & Weaknesses
Table 4-5: AstraZeneca Plc - Strengths & Weaknesses